I'm a small business owner and investor. Previously, I was an intelligence officer and defense consultant with six years of experience in conflict zones.
I use a bimodal portfolio, applying strong defense and offense at the same time. US treasuries, precious metals, and short sales comprise more than 50%. I stake the rest in high payout opportunities, including deep value, distressed debt, special situations, and turnarounds.
I am a high yield/distressed credit and deep value/reorg equity analyst. I have fundamental research and buy-side direct investing experience of 22 years in four continents, last 13 years of which were in US and 9 years in three emerging nations - India, Australia and Oman.
My last job was with Dalton Investments LLC in Los Angeles, where I spent 13 years as Managing Director analyzing special situations, high yield/distressed credits, bank loans and reorg equities. As a generalist, I looked at more than 400 companies and gained knowledge in insolvency proceedings. By participating in creditor committees, I also gained expertise in corporate reorganization and rescue financing. Currently I am looking for a suitable employment opportunity.
Prior to Dalton, I worked at Al Ahlia Securities in Muscat, Oman, for more than two years as Head of Research for a $100 mn equity fund. Middle East and North African equities were key investing targets.
Prior to Al Ahlia, I worked as Head of Research at ANZ Investment Bank for two years in Syndey, Australia and Mumbai, India. While setting up an Indian asset management company for Australian bank ANZ, I gained research experience in Australian mining, minerals, telecom and tourism sectors.
Prior to ANZ, I worked at Unit Trust of India, Indias largest mutual fund at that time, between March 1992 and December 1996. I personally visited more than 300 companies in various parts of India and analyzed/invested in their debt/equity.
I hold an MBA from Marshall School of Business, University of Southern California. I also hold an MBA from Indian Institute of Management, Ahmedabad IIM-A. I hold a B.Tech in Aerospace Engineering from Indian Institute of Technology, Kharagpur IIT-KGP. I am Chartered Financial Analyst CFA and a member of CFA Institute/CFA society of Los Angeles.
The goal as everyone knows, is to buy good stocks at a discount and sell-short overvalued stocks when they are at a premium. I have a background in business and deal with internal models, analysis, sales pitches and ad information daily. In my downtime, I am enthusiastic about the markets highs, lows and volatility. I believe in real lags between market and business reactions, with the former often in advance of the latter, and vice versa. I look to call manic enthusiasm with a distinct opportunity to go short. A change in sentiment is all it takes. I research fundamentals while scavenging for value.
Andrew Left's Citron Research (http://www.citronresearch.com/) (formally known as Stocklemon.com) seeks to expose companies whose management is in some way misleading investors. Left digs into SEC filings, financials, management histories and other data to uncover such situations, and he is usually short the stocks he writes about. Mr. Left has been publishing for 7 years and has created a track record that is unrivaled in short selling. Mr. Left has been cited in Barron's, Wall St Journal, CNBC and other major publications repeatedly for his work. Mr. Left was also an invited speaker at the reknown Master Investor Conference.
Visit: Citron Research (http://www.citronresearch.com/)
Professional investor and overall good guy.
By reading Mako Research reports, you agree to use the information at your own risk. In no event should Mako Research or any affiliated party be liable for any direct or indirect trading losses caused by information contained in the research reports. Research reports are not investment advice or a recommendation or solicitation to transact any securities. Mako Research is not a registered investment advisor. You agree to do your own research and due diligence before making any investment decision with respect to securities covered herein. You should assume that Mako Research stands to profit in the event the issuer’s stock declines. Research reports may contain opinions, which are based upon generally available public information, field research, inferences and deductions through due diligence and analytical processes. All information is believed to be accurate and reliable, and has been obtained from public sources. Mako Research makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information. All expressions of opinion are subject to change without notice, and Mako Research is not obligated to update or supplement any reports or any of the information, analysis and opinion contained in them. You should assume that Mako Research has and/or will submit findings with the Securities Exchange Commission, and other entities that may find the information useful.
PhaseFive initiates research-intensive analysis of Healthcare and Biotechnology companies using groundbreaking scientific intelligence tools. We focus on long/short event-driven opportunities centered on clinical, regulatory and early commercial development.
Our research approach relies on synergizing diverse talents. PhaseFive’s team is built on the knowledge and vast experience of Neurobiochemistry PhDs, Big Data experts and seasoned Life Science investors. Our track record reflects our ability to assess a company’s true fair value at critical stages, looking beyond hype and misunderstood perceptions.
PhaseFive focuses on catalyst events in small-to-medium cap Healthcare companies. These catalyst events include clinical trial outcomes, regulatory procedures and commercial developments.
I am currently an investor with previous experience in corporate M&A and private equity. I look for both long and short opportunities in small to mid capitalization stocks that are often ignored or overbought in the marketplace. In long opportunities, I seek out deep value that is overlooked by the general public. In short opportunities, I look for highly promoted companies that are likely to be misrepresenting information to investors. I conduct the necessary due diligence to present the facts and try to eliminate the asymmetrical information gap that exists in these opportunities.
Edward Schneider is a managing director of Quan Management LLC. Mr. Schneider has over 25 years of investment experience, including 18 years managing technology funds in both quoted equities and venture capital. Mr. Schneider holds a CFA designation, an MBA from Thunderbird and a BA from Emory University.
#11 Ranked Blogger for 2014 from over 4,100 bloggers - TipRanks
Quan Technology Fund - #1 Ranked Fund in Europe for 2014 with a net return of +71% - Preqin Fund Ranking
I have spent over thirty years in the financial services industry and I am the author of Dead Companies Walking: How a Hedge Fund Manager Finds Opportunity in Unexpected Places, an Amazon Best Book of the Month. Since 1991, I have managed the hedge fund Crown Capital in Marin County, California.
Robert W. Walter, Esq. is a securities attorney officing in Colorado. He represents small and mid-cap companies in capital market transactions including IPOs, follow-on offerings, private placements, and M&A. He also is active in representing whistleblowers before the SEC in connection with potential violations of the federal securities laws.Since 2000 and 2012, he has also served as an instructor of continuing professional education (CPE) courses for the AICPA and IASeminars, London, England, respectively. He has written ten CPE courses and six books on SEC reporting and capital markets, corporate governance, small business financing, business ethics, business law, and financial statement fraud. Mr. Walter received the AICPA's Outstanding Discussion Leader award in 2015, 2014 and 2013, placing him among the top 20 AICPA instructors nationally. The opinions he expresses are his own.
The CPE courses authored by Mr. Walter include: Detecting and Investigating Financial Statement Fraud; Management's Discussion and Analysis Workshop; Corporate Governance Fundamentals; Understanding the Foreign Corrupt Practices Act; SEC Reporting for International Companies; Advanced Business Law for CPAs; Real World Business Ethics (for tax practitioners, for audit and accounting, and for business and industry); Tough Economic Times, Current Issues and Critical Ethical Judgments; AICPA's Guide to Financing the Small Business; Public Reporting Responsibilities: Putting Your Best Foot Forward; and the SEC and PCAOB Quarterly Update. Mr. Walter speaks extensively on SEC and PCAOB matters, IFRS, business ethics, and risk management.at national and state conferences.
Mr. Walter received his J.D. from the Duke University School of Law, and holds a Bachelor of Science degree in Business from Colorado State University. In 2012, he completed coursework such that he is now eligible to sit for the CPA exam. He is admitted to practice before the United States Supreme Court, the Federal Circuit Court of Appeals, the 10th Circuit Court of Appeals, and the Federal District Court of the State of Colorado. He is a member of the District of Columbia bar, the Colorado bar, Mensa, the Author's Guild, the American Society of Journalists and Authors, and Beta Gamma Sigma. His is also a former member of the Standing Advisory Group to the Public Company Accounting Oversight Board (2004 – 2005), which advises the PCAOB in carrying out its standard-setting responsibilities and consists of approximately 33 members from throughout the U.S. with expertise in accounting, auditing, corporate finance, and corporate governance.
One of the first stocks Michael Goode looked to invest in when he first started investing in 2005 was a small company traded on the Pinksheets called US WindFarming. During his research, Michael found out that the CEO had previously been convicted of criminal stock fraud and had served time in jail for a scheme that purported to turn base metals into gold. Michael decided not to invest and six months later the SEC sued the company, alleging that all the press releases were fake and the company was a sham that existed for the sole purpose of selling shares to gullible investors in order to enrich the insiders.
Following that experience, Michael Goode became a bit of a cynic. While he called himself a value investor and even briefly ran a value investing newsletter, his true love was exposing fraud and failed businesses. At his blog GoodeValue.com, sometimes syndicated on SeekingAlpha.com, he blasted companies such as H2Diesel (later renamed New Generation Biofuels), Cytocore (later sued by the SEC), Remote MDX (later panned by Andrew Left of Citron Research and Carol Remond of Dow Jones Newswires), and Noble Roman’s Pizza (on which he was quoted in multiple articles in the Indianapolis Business Journal).
Michael Goode has continued to shine a light on stock promotions and the people behind them on his trading blog, GoodeTrades.com. He has blogged about lawsuits involving stock promoters (a couple more) and he has exposed the multiple websites used by certain stock promoters. He remains a full-time stock trader; you can see most of his trades on Profit.ly.
Michael Goode graduated from Earlham College in 2004 and obtained a Masters Degree in Cognitive Psychology in 2007, from Washington University in St. Louis. He is the managing member of MorningLightMountain LLC, the owner of GoodeTrades.com, OTCMicroCapResearch.com, and all other content he writes online. Michael Goode has never been charged with or convicted of any crime whatsoever.
The Investor Protection Association (IPA) is devoted to performing research, investigation and publication of information which concerns financial fraud and dishonest stock market practices taking place in companies that trade on stock exchanges in the United States, with a focus on small cap equities and penny stocks.
The most important purpose of our service is to educate and help hard working, decent investors by informing them of fraud and manipulation in specific stocks. By performing scrupulous and professional research, uncovering crucial information and publishing it, we may help these investors make a more informed decision and avoid losing substantial amounts of money.
On the other hand, our service also caters to sophisticated short-biased traders by providing excellent, in terms of risk-to-reward ratio, trading setups which occur primarily as a result of inflated prices in stocks which are subject to promotional campaigns (so called Pump & Dump).
TheStreetSweeper recently named Sonya Colberg as Senior Editor. About three years ago, she became senior investigative reporter of TheStreetSweeper, a website devoted to exposing fraud, shenanigans and lousy business practices of public companies. Sonya had worked more than two decades as an editor and reporter for two major newspapers, including the recent Warren Buffett acquisition, Tulsa World. Among others, the Associated Press, Great Plains Journalism Awards, The Gerald Loeb Awards and the Society of Professional Journalists have recognized Sonya’s investigative, feature, health, news and business stories. A fearless investigative reporter, Sonya loves nothing better than calling out the shysters and bumblers who quietly work to separate investors from their hard-earned money.
James Grant, financial journalist and historian, is the founder and editor of Grant’s Interest Rate Observer, a twice-monthly journal of the investment markets. He is, in addition, the author of five books on finance and financial history: Bernard M. Baruch: The Adventures of a Wall Street Legend (Simon & Schuster, 1983), Money of the Mind (Farrar, Straus & Giroux, 1992), Minding Mr. Market (Farrar, Straus & Giroux, 1993) and The Trouble with Prosperity (Times Books, 1996), and Mr. Market Miscalculates (Axios Press, 2008). John Adams: Party of One, a biography of the second president of the United States, was published in March 2005 by Farrar, Straus & Giroux as well as Mr. Speaker! The Life and Times of Thomas B. Reed, the Man Who Broke the Filibuster (Simon & Schuster). His new book, “The Forgotten Depression, 1921: the Crash that Cured Itself,” will be published in the fall by Simon & Schuster. Mr. Grant’s television appearances include “60 Minutes,” “The Charlie Rose Show,” “CBS Evening News,” and a 10-year stint on “Wall Street Week”. His journalism has appeared in a variety of periodicals, including the Financial Times, The Wall Street Journal and Foreign Affairs, and he contributed an essay to the Sixth Edition of Graham and Dodd's Security Analysis (McGraw-Hill, 2009). Mr. Grant, a former Navy gunner's mate, is a Phi Beta Kappa alumnus of Indiana University. He earned a master's degree in international relations from Columbia University and began his career in journalism in 1972, at the Baltimore Sun. He joined the staff of Barron’s in 1975 where he originated the “Current Yield” column. He is a trustee of the New York Historical Society. He and his wife, Patricia Kavanagh M.D., live in Brooklyn. They are the parents of four grown children.
Copperfield Research is the pseudonym of a research team focusing on publicly traded equities. As of the publication date of our articles, we may have long or short equity positions in the companies covered. We do not discuss unpublished reports, or provide any advanced warning of future reports to others. Due to the danger of retaliation, our reports are written under a pseudonym. Please read our Disclaimer on the front page of every opinion piece before reading any of the material.
Trinity Research Group ("Trinity") was established in 2014 by a group of international individual investors each with decades of investment experience in China and the USA. Trinity focuses exclusively on opportunities, long or short, created by false information and/or inaccurate market beliefs. Trinity leverages the principals' substantial local networks to conduct extensive fundamental, bottoms up due diligence of misunderstood companies.
Trinity invests the principals' money exclusively and does not manage assets for others or advise clients.
Trinity publishes research for information and educational purposes only, and our research should not be considered investment advice. Refer to the disclaimer below.
Trinity Research Group strongly recommends that every investor conduct his/her own due diligence before buying or selling any security. Trinity does not guarantee in any way that it is providing all of the information that may be available. You should be aware that the principals of Trinity might hold a position, long or short, in any of the securities discussed in our research.
Our research and report expresses our opinions, which we have based upon publicly available information, third-party buy- or sell-side research (whenever referenced), our own due diligence, and inferences and deductions through our analysis. Trinity believes all information contained in its research is accurate and reliable, and has been obtained from sources it believes to be accurate and reliable. However, such information is presented “as is,” without warranty of any kind, whether express or implied. Trinity makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. All expressions of opinion are subject to change without notice, and Trinity is not obligated to update any of its opinions or research after making it available.